Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1978 Nov;305(2):103-8.
doi: 10.1007/BF00508278.

Release of noradrenaline by labetalol in the rat anococcygeus muscle

S A Doggrell, D M Paton

Release of noradrenaline by labetalol in the rat anococcygeus muscle

S A Doggrell et al. Naunyn Schmiedebergs Arch Pharmacol. 1978 Nov.

Abstract

The effects of labetalol on the accumulation and spontaneous release of (--)-[3H]noradrenaline, and on contractile responses to exogenously applied (--)-noradrenaline were studied in the isolated anococcygeus muscle of the rat. 1. Labetalol (3 x 10(-7)--10(-4)M) inhibited the accumulation of (--)-[3H]noradrenaline. 2. Labetalol (10(-6)--10(-4)M) and guanethidine (6 x 10(-6) M) increased the spontaneous release of [3H] following incubation of the muscle with (--)-[3H]noradrenaline. Nortriptyline (10(-6) M) had no effect on the spontaneous release of [3H], antagonised the increased release of [3H] produced by 6 x 10(-6) M guanethidine but not that observed with 10(-5) M labetalol. Labetalol (5 x 10(-6) M) markedly increased the loss of tritiated deminated metabolites with little change in the loss of (--)-[3H]noradrenaline. 3. Labetalol (10(-7)--10(-5)M), alone or in the presence of 10(-6) M nortriptyline, had no effect on contractile responses to (--)-noradrenaline. 4. Following pretreatment with 6-hydroxydopamine (10(-3)M for 3 h) to deplete endogenous noradrenaline stores, labetalol (10(-7)--10(-5) M) inhibited responses to exogenously applied (--)-noradrenaline. 5. These results suggest that, in the rat anococcygeus muscle, labetalol is a noradrenaline releasing agent and an alpha-adrenoceptor antogonist.

PubMed Disclaimer

References

    1. Biochem Pharmacol. 1977 Nov 15;26(22):2137-43 - PubMed
    1. Br J Pharmacol. 1975 Aug;54(4):481-8 - PubMed
    1. Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):681-4 - PubMed
    1. J Pharm Pharmacol. 1978 Jul;30(7):453-4 - PubMed
    1. Br J Pharmacol. 1978 Mar;62(3):380P - PubMed